RxDoctor Payments Data

David Armstrong, DPM

Podiatrist · Los Angeles, CANPI 1427160902

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $598,003 of the $694,935 with a category attached, or 86.1%. Podimetrics, Inc. accounts for 63.0% of it on its own, with 41 other manufacturers making up the rest. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$694,935in general payments, 2019–2025

Across 160 payments — averaging $4343.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Podimetrics, Inc.$438K
  • Convatec Inc.$48K
  • Molnlycke Health Care US, LLC$44K
  • Nevro Corp.$25K
  • Cardiovascular Systems Inc.$21K
  • Kerecis Limited$19K
  • plus $100K from 36 others
$686,928in research payments, 2019–2025

Across 41 payments — averaging $16,754 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GE HealthCare$332K
  • Polarityte, Inc.$227K
  • Geistlich Pharma, North America, Inc.$65K
  • Ipsen Innovation$29K
  • Medline Industries LP$26K
  • Smith+Nephew$8K

What the payments were for

  • Consulting fees$598,00386%
  • Speaking & faculty fees$38,7866%
  • Grants$30,3214%
  • Travel & lodging$24,1943%
  • Food & beverage$3,6071%
  • Education$240%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$694,935 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California

Medicare billing

Part B allowed, 2024
$64,571
Medicare patients
100
Services billed
480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other podiatrist in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →